Total Funding
64
46
Total FundingVenture - Series Unknown raised
Growth Score
-2 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
106287
MabGenesis is a biopharmaceutical startup company that offers therapeutic monoclonal antibody drugs for both humans and companion animals.
Kurosawa Gene: CTO- Katsuhiro Shinjo: Co-Founder, Chief Executive Officer & Representative Director
About the Company
MabGenesis is a biopharmaceutical company that provides therapeutic monoclonal antibody drugs in the human and animal fields. They have an antibody library and monoclonal antibody isolation technology. With the provision of novel antibody therapeutics, the firm helps to relieve symptoms and improve the quality of life of individuals suffering from.
